HCPCS Level II code J0175 represents an injectable monoclonal antibody product, donanemab-azbt, 2 mg, billed as a single-drug injection for infusion therapy; the service type is intravenous infusion/injection of a biologic agent, and the typical site of service is an outpatient infusion center or hospital outpatient department where administered under clinician supervision.

For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Antibody-Drug Conjugates, Umbilical Cord Blood Harvesting and Storage for Future Use (for Indiana Only).